...
首页> 外文期刊>BMC Musculoskeletal Disorders >An open-label randomized multi-Centre study to evaluate anterior controllable Antedisplacement and fusion versus posterior Laminoplasty in patients with cervical ossification of the posterior longitudinal ligament: study design and analysis plan (STAR)
【24h】

An open-label randomized multi-Centre study to evaluate anterior controllable Antedisplacement and fusion versus posterior Laminoplasty in patients with cervical ossification of the posterior longitudinal ligament: study design and analysis plan (STAR)

机译:一个开放标签随机的多中心研究,以评估前纵向韧带颈椎骨化患者前可控的前剥离和融合与后椎间膜成形术的研究:研究设计和分析计划(星)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In treating patients with cervical ossification of the posterior longitudinal ligament (COPLL), a novel surgery technique - anterior controllable antedisplacement and fusion (ACAF) suggested promising clinical benefits in recent exploratory studies. This is a multicentre, randomized, open-label, parallel-group, active controlled trial that will compare the clinical benefits of ACAF versus conventional posterior laminoplasty (LAMP) in severe COPLL patients. A total of 164 patients will be enrolled and randomized in a 1:1 ratio to either ACAF or LAMP group. The primary efficacy measure is cervical- Japanese Orthopaedic Association (C-JOA) recovery rate at 12?months post operation, which is to be derived by Hirabayashi’s method from JOA data (range, 0 [worst] to 17 [normal condition]). Other important secondary efficacy endpoints include visual analogue scale (VAS) pain score (range, 0 [no pain] to 10 [most severe]), 10-item neck disability index (NDI, a total range of 0 to 50 points, the highest index the worst) and 6-level Nurick disability grade (range, 0 [mild] to 5 [severe]). Safety endpoints including adverse events, perioperative complications, and adverse events of special interest will also be assessed in this study. Full analysis set for baseline and efficacy data analyses according to the intention-to-treat principle will be established as the primary analysis population. Analysis of covariance (ANCOVA) will be used to analyze the C-JOA recovery rate, with random stratification factors (if appropriate) and the treatment group as fixed factors, and the baseline level of C-JOA score as covariate. This study is designed to demonstrate the clinical benefits of ACAF as compared to conventional LAMP in COPLL patients. It will provide clinical evidence that the novel surgery technique – ACAF might be more favorable in treating patients with severe cervical ossification of the posterior longitudinal ligament. (Words: 290). ClinicalTrials.gov number, NCT04968028 .
机译:在治疗后纵韧带(COPL111)的宫颈骨化患者中,一种新型手术技术 - 前可控的前剥离和融合(ACAF)在最近探索性研究中提出了有前途的临床效益。这是一个多中心,随机,开放标签,并行组,有效对照试验,将比较严重的Copll患者的ACAF与常规后层层压术(灯)的临床益处。总共164名患者将在1:1的比例中注册并随机分配到ACAF或灯组。初级疗效措施是宫颈 - 日本矫形协会(C-JOA)回收率12?持续时间,其由Hirabayashi的方法来自JOA数据(范围,0 [最差]至17 [正常条件])。其他重要的二次疗效终点包括视觉模拟量表(VAS)疼痛评分(范围,0 [无疼痛]至10 [最严重]),10项颈部残疾指数(NDI,总范围为0至50点,最高指数最差)和6级纯净残疾等级(范围,0 [温和]至5 [严重])。在本研究中还将评估包括不良事件,围手术期并发症和不良事件的安全终点。根据意图对治疗原则进行全分析,用于基线和功效数据分析将作为主要分析人口建立。协方差分析(ANCOVA)将用于分析C-JOA回收率,随机分层因子(如果合适)和治疗组作为固定因子,以及C-JOA评分的基线水平为COVARIED。本研究旨在展示ACAF的临床益处与COPLL患者的常规灯相比。它将提供临床证据,即新型手术技术 - ACAF在治疗后纵韧带的严重宫颈骨化患者方面可能更有利。 (单词:290)。 ClinicalTrials.gov号码,NCT04968028。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号